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conduction abnormalities and increasing myelination on MRI 
scans. Pts transplanted later in the course of the disease have had 
less dramatic but measurable improvements, particularly in lan- 
guage and cognitive skills. We hypothesized that UCB-derived 
cells migrated to brain and differentiated into non-hematopoietic 
cells in these pts but could not study this filrther with non-inva- 
site techniques. Unfortunately, one baby with advanced Krabbe 
disease, transplanted with a UCB donor of the opposite sex at 8 
months of age, died 1 yr post transplant. Her brain was studied to 
determine whether donor derived cells were present at the time of 
her death. Brain tissue was fixed in formalin, sectioned and stained 
with histochemical stains for glial and neuronal tissues and coun- 
terstained with FISH for the XY chromosomes to differentiate 
donor and host cells. YVe found extensive distribution of host cells 
in blood vessels, peri-ventricular tissues, white matter of the cere- 
bral cortex, cerebellmn, choroid plexis and forebrain parenchyma. 
Differentiation of donor ceils to microglia and choriod plexus 
cells was present, but differentiation i to cells of neuroectodermal 
origin (e.g neurons, astrocytes, or l igodendrocytes) was not 
found. These results demonstrate hat donor-derived UCB cells 
can extensively distribute in brain tissues after UCB transplanta- 
tion. Transdifferentiation across germ cell layers was not demon- 
strated. 
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EMBRYONIC STEM CELLS SURVIVE AND PROLIFERATE AFTER 
INTRA-PERITONEAL IN UTERO TRANSPLANTATION AND PRODUCE 
TERATOCARCINOMAS 
Nedelcu, E.1; Sriwzstava, A. I; Vartei, ~L 2; Assatoztria~.r, G. 1; C[at~der, 
Ed 1. Bone 3/larrow Tva*zsplaJzt, UMversity of CA, San Diego, La 
rid~a, G4; 2. Umversity of CA, San Diego, La Jolla, Gq. 
Embryonic stem cells (ESC) support murine fetal development 
if injected in blastocysts and can engraft in conditioned newborns. 
However, little is known about their behavior after the in utero 
transplantation. The aim of this research is to establish a model 
for study of the in vivo differentiation of ESCs after the in utero 
transplantation. We hypothesize that the in ntero transplanted 
ESC integrate into the fetus and, based on their pluripotency, may 
represent a therapeutic alternative for prenatally diagnosed is- 
eases. ESC genetically engineered to express yellow fluorescent 
protein (YFP-ESC) were transplanted intra-peritoneally in ntero 
at E 14-15. The presence of YFP signal was analyzed in various tis- 
sue of the viable offsprings at different ages (4-8 weeks) and was 
quantified by digitalized fluorescence microscopy on analysis of 
tissue supernatants. The YFP-ES-derived cells were found only in 
the liver without any evidence of YFP signal in other organs. 
Extensive peritoneal teratocarcinomas with snpradiaphragmatic 
involvement was generated after the ESC in in utero transplanta- 
tion in allogeneic mice. Also, clinical and histopathological pic- 
tures suggestive of graft-versus -host disease were present in two 
out of five haploidentical mice. Studies that address the issue of 
ESC differentiation i to hepatic ceils within this model are in 
process and will be presented. The promise and the potential risks 
of the ESC transplantation have to be carefully considered. 
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BRAIN FROM BLOOD IN HUMANS 
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Adult hematopoietic stem cells (HSC) have the capacity to 
self-renew and differentiate into all hematopoietic lineages. 
Recent  studies in humans have found that bone marrow 
derived stem cells can function as regenerative progenitors for 
the liver, kidney, heart, musculoskeletal tissue, and gastroin- 
testinal tract. In the brain, animal studies have found that 
murine HSC can differentiate into neurons of the adult mouse. 
Following these reports, we investigated whether human HSC 
contribute to adult human neurogenesis. Autopsy brain speci- 
mens from female recipients of therapeutic HSC transplanta- 
tion from male donors where analyzed for cells containing Y
chromosome. In these cases, hippocampai ceils containing Y 
chromosome were found. Most Y-positive cells were non-neu- 
ronal, with transgender neurons (beta-3-tubulin positive) com- 
prising only 1% of total neurons. In addition, these Y-chromo- 
some neurons were not a product of fusion, as evidenced by 
presence of only one X chromosome. Our findings demonstrate 
that postnatal human neuropoiesis i present and that human 
hematopoietic cells have the capability to generate neurons, 
albeit at a very low level. The biologic implications uggest 
that the HSC or a hematopoiet ic  progeni tor  esponds to 
instructive neurotrophic ues, crosses the blood-brain-barrier, 
diffuses into central nervous system tissues and activates previ- 
ously dormant neuron-specific genetic programming. Together 
these observations challenge the restricted notion of unidirec- 
tional ontogenic maturation and uncover a mount ing HSC 
plasticity repertoire. Our findings also suggest hat human 
HSC may serve as a therapeutic source for regenerative neu- 
ropoiesis. 
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AUTOLOGOUS STEM CELL COLLECTION IN POLYCYTHEMIA VERA 
Lrola, L.; Gorsky, M.; SiMtsylla, K; ScigliaT~o, E.; Frztc,~tma,, S. 
Hematology, 3do~mt Shzai Medical Center, New York, NIT. 
Allogeneic Tx can eradicate MF. We reported resolution of MF 
after ablative syngeneic Tx in a patient with spent phase PV (B J 
Haematol f i7:246). Hence GvL is not required to eliminate MF. 
Ablation with ASCT could represent a major advance for spent 
phase PV. In PV, the optimal t iming and the influence of 
organomegely, myelosnppression a d MF on autologous collec- 
tion are uknown. Between 08/94 and 01/02, 16 pts with PV 
underwent stem cell collection. Mobil ization was G-CSF 10 
mcg/kg x 5d. Min imum target was 2.5 X 106 CD34+/kg. All 
myelosnppression but anagrelide was stopped aminimum of 2 w~ 
before collection. M:F ratio was 7/9. Median ages at Dx and col- 
lection were 47 and 57. Organomegaly was present in 10 pts 
(63%) and moderate or extensive MF in 4 pts (25%). Seven pts 
were receiving myelosuppression. Three pts had clonal cytogenet- 
ic abnormalities. For the whole cohort median TNC and CD34+ 
counts were 8.3 X 108/kg and 4.98 X 10~/kg. No organomegaly 
predicted for higher TNC and lower CD34+ contents but differ- 
ences were NS (p=0.16 and 0.1). MF adversely affected TNC 
(p=0.05) but not CD34+ (p=0.8). Time from Dx and myelosuppre- 
sion had no influence on TNC and CD34+ . One pt had CD34+ 
below target (2.2 X 106/kg). See table for details. Autologous col- 
lection of peripheral blood stem cells is feasible in PV pts several 
years after DX. Organomegaly and MF are not contraindications 
for collection. Myelosuppresion up to 2 weeks prior to mobiliza- 
tion appears safe in terms of cell contents. Studies are now 
required to determine the safety and efficacy of ablation and 
ASCT to reestablish effective hematoposiesis in spent PV. 
TNC e8/kg CD34+ e6&g 
N Y N Y 
Organomegaly 12,2 6.6 ! 3,06 8.30 
TfromDx>10y 0.7 8.7 ! 2.9 i i .9 f 
MF 10.3 3.8 i 6.09 3.25 
Myelosuppression 8.4 9.1 i 3.7 9.8 
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PREFERENTIAL EXPANSION OF CORD BLOOD EARLY PROGENITORS 
ENABLED BY LINEAR POLYAMINE COPPER CHELATORS 
Peled, T.t; Nagler, A.2; Treves, A.J. 1 1. Gamida-Cell, Jer~lsalem, 
Israel; 2. Sheba Medical Center, T l Hashomer, Israel. 
We demonstrated that the polyamine copper chelator, tetraeth- 
ylenepentamine (TEPA), extended the long term cord blood 
CD34+ cultures (Peled tal, Brit. J. Haematol. 116:655 2002 ).To 
study the effect of TEPA on long-term expansion, we adopted a
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